Virtual Medicinal Product (VMP)
-
Acamprosate 333mg gastro-resistant tablets
Name Details
Current Name
Acamprosate 333mg gastro-resistant tablets
|
Start Date
21-10-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Gastro-resistant tablet
- Ontology Form/Route
- tabletgastro-resistant.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N07BB03
BNF |
Current BNF
04100100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04100100
|
Start Date
05-04-2011
|
End Date
03-04-2022
|
Previous BNF
04100000
|
Start Date
23-02-2005
|
End Date
04-04-2011
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42267511000001104 |
22-09-2023 |
|
323342002 |
21-10-2002 |
21-09-2023 |
VMP Ingredients
Name
Acamprosate calcium
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
333
Strength and UOM (Dmr)
Parent Products
-
VTM
Acamprosate
-
VMP
(Current) Acamprosate 333mg gastro-resistant t...
Virtual Medicinal Product Pack (VMPP) Information